Outsourcing Insights: Focusing On Innovation

By Kate Hammeke, research manager, Nice Insight

In 2011, innovation was a major topic among the various players in the drug development industry. Feedback from clients and sponsor-side industry personnel prompted a change in the outsourcing drivers included in the Nice Insight Pharmaceutical and Biotechnology Outsourcing survey, such that innovation — or the ability to improve in-house capabilities with customized solutions — replaced accessibility for the 2012 research cycle. The results from the Q1, 2012 survey indicated that while important, innovation ranked sixth after quality, reliability, productivity, regulatory track record, and affordability with respect to partner selection.

Used with permission from Life Science Leader magazine.